Skip to main content
BGLC logo

BGLC

BioNexus Gene Lab Corp
$2.03 +0.03 (+1.50%) At close · Jul 2
Market Cap
$4.91M
Shares
2,417,314

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 2
Total Value: $496
Total Shares: 232

Institutional Ownership Trend

4 quarters

Holder Concentration

Across 2 13F filers · Δ vs Dec 31, 2025
Top Holder
99.6%
Jun 2025 → Mar 2026 · range 65.8% – 100.0%
−0.4 pts
Top 5
100.0%
Jun 2025 → Mar 2026 · range 100.0% – 100.0%
0.0 pts
Top 10
100.0%
Jun 2025 → Mar 2026 · range 100.0% – 100.0%
0.0 pts
HHI
9,920
Jun 2025 → Mar 2026 · range 5,497 – 10,000
Highly concentrated−80

Quarterly Activity

vs Dec 31, 2025
New
2
Increased
0
Decreased
0
Sold Out
1
Unchanged
0
Holder count: +1
Institutional value: -99.7%
Shares held: -99.5%

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
Institution Previously Held Last Value (USD) Open
Showing 2 of 2
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1737523 CUSIP 090628306 Visit website Investor relations